Pharmacotherapy of arterial hypertension in patients with chronic kidney disease in real clinical practice

Pliasheshnikov, M.A.; Titova, Z.A.; Volkova, Yu.V.; Zhgut, O.G.

doi:10.32756/0869-5490-2020-3-80-84

CPT

2020

DOI: 10.32756/0869-5490-2020-3-80-84

|View full text |Cite

Pharmacotherapy of arterial hypertension in patients with chronic kidney disease in real clinical practice

M.A. Pliasheshnikov¹,

Z.A. Titova²,

Yu.V. Volkova³

et al.

Abstract: котерапия артериальной гипертонии у больных с хронической болезнью почек в реальной клинической практике. Клин фармакол тер 2020;29(3). [Pliasheshnikov MA, Titova ZA, Volkova YuV, Zhgut OG. Pharmaco therapy of arterial hypertension in patients with chronic kidney disease in real clinical practice. Kliniches kaya farmakologiya i terapiya = Clin Pharmacol Ther 2020;29(3):80-84 (In Russ.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Treatment of arterial hypertension in patients with chronic kidney disease from the perspective of the 2023 European recommendations

Sigitova

2024

Kazan Med J

View full text Add to dashboard Cite

Hypertension is a common disease in the adult population with an increasing tendency, it leads to damage to target organs, including the kidneys, with the development of chronic kidney disease, and increases the risk of cardiovascular complications and mortality. The paper provides an overview of the European guidelines for the treatment of arterial hypertension, updated in 2023, approved by the European Kidney Association and the International Society of Hypertension, in the context of chronic kidney disease — in comparison with the previous European guidelines (2018) and the current National clinical guidelines (2021). The updated recommendations retain the main provisions of the strategy for the treatment of arterial hypertension with chronic kidney disease of the 2018 European recommendations. Updates have been made to the classification of the main and additional groups of drugs for the treatment of arterial hypertension. For the first time, a new group of “special drugs for the treatment of concomitant pathology” has been added, including three classes of drugs: (1) neprilysin receptor antagonists, (2) sodium-glucose transporter-2 inhibitors, (3) non-steroidal mineralocorticoid receptor antagonists. A step-by-step algorithm for choosing antihypertensive drugs for arterial hypertension depending on the stage of chronic kidney disease has been updated. Recommendations for the treatment of resistant arterial hypertension were covered in detail. Some new recommendations were included for blood pressure targets based on albuminuria levels and other factors. A slightly modified scale for assessing cardiovascular risk in patients with arterial hypertension was presented and the role of chronic kidney disease stages III–V as an independent factor of high or very high cardiovascular risk was confirmed.

show abstract

Treatment of arterial hypertension in patients with chronic kidney disease from the perspective of the 2023 European recommendations

Sigitova

2024

Kazan Med J

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Pharmacotherapy of arterial hypertension in patients with chronic kidney disease in real clinical practice

Cited by 1 publication

References 10 publications

Treatment of arterial hypertension in patients with chronic kidney disease from the perspective of the 2023 European recommendations

Treatment of arterial hypertension in patients with chronic kidney disease from the perspective of the 2023 European recommendations

Contact Info

Product

Resources

About